Evidence map›Paper›PMID 21533027›Full record

ArticlePLoS genetics2011

Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum.

Daria Van Tyne, Daniel J Park, Stephen F Schaffner, Daniel E Neafsey, Elaine Angelino, Joseph F Cortese, Kayla G Barnes, David M Rosen, Amanda K Lukens, Rachel F Daniels and 21 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genomics reveals heterogeneousmedRxiv : the preprint server for health sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Genome-wide SNP analysis ofFrontiers in genetics · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Life (Basel, Switzerland) · 2020
    Article
  20. Clinical microbiology reviews · 2019
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 7 institutions in 3 countries.

Daria Van TyneDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Daniel J Park
Stephen F Schaffner
Daniel E Neafsey
Elaine Angelino
Joseph F Cortese
Kayla G Barnes
David M Rosen
Amanda K Lukens
Rachel F Daniels
Danny A Milner
Charles A Johnson
Ilya Shlyakhter
Sharon R Grossman
Justin S Becker
Daniel Yamins
Elinor K Karlsson
Daouda Ndiaye
Ousmane Sarr
Souleymane Mboup
Christian Happi
Nicholas A Furlotte
Eleazar Eskin
Hyun Min Kang
Daniel L Hartl
Bruce W Birren
Roger C Wiegand
Eric S Lander
Dyann F Wirth
Sarah K Volkman
Pardis C Sabeti
Broad Institute · USMassachusetts Department of Public Health · USHarvard University · USCheikh Anta Diop University · SNUniversity of California, Los Angeles · USUniversity of Ibadan · NGUniversity of Michigan · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Training Grant in Genomic Analysis and InterpretationT32HG002536 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Valerie A Arboleda, Harold Pimentel · 2002 to 2026
$8.6M
IMMUNOLOGY AND INFECTIOUS DISEASES IN PUBLIC HEALTHT32AI007638 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI RUBIN, ERIC J. · 2000 to 2014
$2.2M
Discovering the Genetic Basis of HypertensionK25HL080079 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKIN, ELEAZAR · 2006 to 2010
$685k
NHGRI NIH HHS T32 HG002536NHLBI NIH HHS K25 HL080079NIAID NIH HHS T32 AI007638NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

The Plasmodium falciparum parasite's ability to adapt to environmental pressures, such as the human immune system and antimalarial drugs, makes malaria an enduring burden to public health. Understanding the genetic basis of these adaptations is critical to intervening successfully against malaria. To that end, we created a high-density genotyping array that assays over 17,000 single nucleotide polymorphisms (∼ 1 SNP/kb), and applied it to 57 culture-adapted parasites from three continents. We characterized genome-wide genetic diversity within and between populations and identified numerous loci with signals of natural selection, suggesting their role in recent adaptation. In addition, we performed a genome-wide association study (GWAS), searching for loci correlated with resistance to thirteen antimalarials; we detected both known and novel resistance loci, including a new halofantrine resistance locus, PF10_0355. Through functional testing we demonstrated that PF10_0355 overexpression decreases sensitivity to halofantrine, mefloquine, and lumefantrine, but not to structurally unrelated antimalarials, and that increased gene copy number mediates resistance. Our GWAS and follow-on functional validation demonstrate the potential of genome-wide studies to elucidate functionally important loci in the malaria parasite genome.

Indexed as

Genetic LociAntimalarialsDrug ResistanceEthanolaminesFluorenesGene DosageGene ExpressionGenetic Association StudiesGenetic VariationGenotypeHaplotypesLinkage DisequilibriumLumefantrineMalaria, FalciparumMefloquinePhenanthrenesAntimalarialsEthanolaminesFluoreneshalofantrineLumefantrineMefloquinePhenanthrenes

Identifiers

PMID21533027
PMCPMC3080868
OpenAlexW1604784023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.